PRACTICA OTO-RHINO-LARYNGOLOGICA
Vol. 100 No. 2 February 2007
Utility of Olopatadine Hydrochloride as Prophylactic Treatment against
Japanese Cedar Pollinosis
Katsumi Masuda and Norimasa Morita
(Kawasaki Medical School, Kagamino Health Insurance Hospital, Satou Memorial Hospital)
Tamotsu Harada, Yukiyoshi Hyo, Kenji Fukutsuji, Toshihiro Tachi,
Masako Uno, Yukitake Mori, Teruhito Aihara, Suetaka Nishiike
and Takeshi Akisada
(Kawasaki Medical School)
Tsuyoshi Yoshihiro
(Yoshihiro ENT clinic)
It is a common knowledge that the number of Japanese Cedar Pollinosis patients is increasing. Prophylactic treatment is recommended as one of the pollinosis treatments.
In 2005, Japanese cedar pollens were extensively scattered. We used the Japan Rhino-conjunctivitis Quality of Life Questionnaire (JRQLQ) to examine the utility of prophylactic treatment using olopatadine hydrochloride in 2005.
As a result, symptoms in the prophylactic treatment group were milder than those in the untreated group. Furthermore, the prophylactic group could maintain a good Quality of Life.
In years with extensive scattering of Japanese cedar pollen, prophylactic treatment with olopatadine hydrochloride is effective, and should be considered when choosing a strongly effective drug for prophylactic treatment.
Key words :
olopatadine hydrochloride, prophylactic treatment, Japanese cedar pollinosis, Japan
Rhino-conjunctivitis Quality of Life Questionnaire (JRQLQ), Quality of Life